Smart device aims to cut pain drug use during surgery
NCT ID NCT03556696
First seen Feb 20, 2026 · Last updated Jun 23, 2026 · Updated 16 times
Summary
This study tested a medical device that automatically gives the pain medicine remifentanil during surgery, based on the patient's heart rate, blood pressure, and a pain index. 52 adults having burn surgery took part. The goal was to see if the device could reduce the total amount of pain medicine needed compared to standard practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL PROCEDURE, UNSPECIFIED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Roger Salengro, CHU
Lille, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remifentanil (pain medicine) and propofol (anesthesia)
What this could lead to
If successful, this could lead to more precise pain control during surgery, potentially reducing side effects and drug use.
What could go wrong
This is a small, early-stage study with only 52 participants. The device may not work better than standard care, and results may not apply to other surgeries or patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.